‘A Significant Assault on Our Health’: Healthcare Policy Leaders Condemn Trump’s Budget Proposal
President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.
President Donald Trump’s 2027 budget proposes deep healthcare cuts, raising concerns about harm to patients and research.
Last week, Trump proposed cutting out insurers and giving Americans cash to buy their own healthcare, claiming it would lower costs. Ali Diab, an economist and CEO of Collective Health, said the plan overlooks the real problem: concentrated payer power, opaque pricing and the financial risk people face without insurance.
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
Some healthcare experts supported Trump’s comments on lowering prescription drug costs, while others criticized his remarks on health coverage.
The decision to eliminate nursing and PA degrees from ‘professional degree’ status isn’t just a financial policy choice; it’s a workforce policy choice. And, unfortunately, it’s moving in the wrong direction at the worst possible time.
Health plans are being asked to adapt quickly, to reconfigure technology, reimagine operations, and anticipate ripple effects that stretch across claims, member engagement, compliance, and workforce strategy.
Americans suffer when hospitals close, nursing homes fall below care standards and mental health services become inaccessible. Immigration should be part of the solution.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
The Trump administration can immediately take these two price transparency administrative actions to reduce costs and improve affordability.
Artificial intelligence (AI) and advanced analytics can assist hospitals as they endure the uncertainty caused by tariffs.
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall.
Time is of the essence, particularly for those with cognitive conditions. The loss of telehealth flexibilities, combined with disruptions to Medicaid, could have devastating consequences for millions of patients with dementia and other cognitive and behavioral conditions.
CMS’ new $50 billion rural health fund seeks to help rural providers sustain care in their communities over the next five years. However, experts believe the program will not be enough to stabilize the finances of rural hospitals — especially in the face of worsening reimbursement issues, an ongoing workforce crisis and billions of dollars’ worth of Medicaid cuts on the horizon.
Clinging to our old models is equivalent to waiting for failure. We need to embrace the tools, team structures, and delivery models that this ongoing crisis demands.
Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce crisis, especially in rural areas, by making it prohibitively expensive for hospitals to hire international clinicians. Critics are also worried that the change could slow the pace of healthcare innovation by discouraging foreign workers from contributing to the tech and research sectors in the U.S.
Healthcare and life sciences are about to face unprecedented AI-driven regulatory changes that will reshape everything from research and development to drug approval submissions. Here are 10 steps healthcare and life sciences organizations should take to strategically prepare.
The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions.